ADPT Adaptive Biotechnologies Corp

Price (delayed)

$37.53

Market cap

$5.27B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.14

Enterprise value

$5.19B

Highlights
The gross profit has grown by 26% year-on-year and by 17% since the previous quarter
The revenue has grown by 24% YoY and by 18% from the previous quarter
ADPT's debt has surged by 162% year-on-year but it is down by 8% since the previous quarter
ADPT's equity is up by 32% year-on-year but it is down by 2.4% since the previous quarter
The company's net income has shrunk by 90% YoY and by 6% QoQ

Key stats

What are the main financial stats of ADPT
Market
Shares outstanding
140.31M
Market cap
$5.27B
Enterprise value
$5.19B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.2
Price to sales (P/S)
44.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
44.77
Earnings
Revenue
$115.91M
EBIT
-$155.14M
EBITDA
-$141.61M
Free cash flow
-$208M
Per share
EPS
-$1.14
Free cash flow per share
-$1.5
Book value per share
$5.21
Revenue per share
$0.83
TBVPS
$6.79
Balance sheet
Total assets
$1.07B
Total liabilities
$346.38M
Debt
$99.56M
Equity
$725.59M
Working capital
$658.19M
Liquidity
Debt to equity
0.14
Current ratio
7.16
Quick ratio
6.89
Net debt/EBITDA
0.54
Margins
EBITDA margin
-122.2%
Gross margin
76.6%
Net margin
-134.1%
Operating margin
-137.6%
Efficiency
Return on assets
-15%
Return on equity
-22.4%
Return on invested capital
-26.4%
Return on capital employed
-16.1%
Return on sales
-133.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADPT stock price

How has the Adaptive Biotechnologies stock price performed over time
Intraday
-2.21%
1 week
4.77%
1 month
8.66%
1 year
-14.02%
YTD
-36.53%
QTD
-6.78%

Financial performance

How have Adaptive Biotechnologies's revenue and profit performed over time
Revenue
$115.91M
Gross profit
$88.74M
Operating income
-$159.48M
Net income
-$155.47M
Gross margin
76.6%
Net margin
-134.1%
The company's net income has shrunk by 90% YoY and by 6% QoQ
Adaptive Biotechnologies's operating income has shrunk by 72% YoY and by 4.4% QoQ
ADPT's net margin has dropped by 53% year-on-year but it is up by 10% since the previous quarter
Adaptive Biotechnologies's operating margin has decreased by 38% YoY but it has increased by 11% QoQ

Growth

What is Adaptive Biotechnologies's growth rate over time

Valuation

What is Adaptive Biotechnologies stock price valuation
P/E
N/A
P/B
7.2
P/S
44.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
44.77
ADPT's EPS is up by 30% year-on-year but it is down by 2.7% since the previous quarter
ADPT's equity is up by 32% year-on-year but it is down by 2.4% since the previous quarter
ADPT's P/B is 24% below its last 4 quarters average of 9.7
ADPT's price to sales (P/S) is 30% lower than its last 4 quarters average of 66.2
The revenue has grown by 24% YoY and by 18% from the previous quarter

Efficiency

How efficient is Adaptive Biotechnologies business performance
The ROIC has plunged by 73% YoY but it has grown by 6% from the previous quarter
ADPT's return on sales has dropped by 52% year-on-year but it is up by 10% since the previous quarter
Adaptive Biotechnologies's ROA has plunged by 50% YoY
The ROE has increased by 3% YoY

Dividends

What is ADPT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADPT.

Financial health

How did Adaptive Biotechnologies financials performed over time
The total assets has grown by 23% YoY but it has contracted by 4% from the previous quarter
Adaptive Biotechnologies's total liabilities has decreased by 7% QoQ but it has increased by 7% YoY
ADPT's debt is 86% smaller than its equity
ADPT's debt has surged by 162% year-on-year but it is down by 8% since the previous quarter
ADPT's debt to equity has surged by 100% year-on-year but it is down by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.